Snap a selfie, spot your real age: How new AI could transform the way doctors treat cancer
A new AI tool called FaceAge can estimate a person's biological age from a selfie, offering doctors a sharper lens to assess frailty and guide treatment plans.
Cancer patients identified as biologically older by FaceAge had poorer survival outcomes, making it a potential tool for personalising care.
While promising, the technology raises ethical concerns around data use, bias, and how knowledge of one's biological age could affect mental health.
WASHINGTON, May 10 — Doctors often start exams with the so-called 'eyeball test' — a snap judgment about whether the patient appears older or younger than their age, which can influence key medical decisions.
That intuitive assessment may soon get an AI upgrade.
FaceAge, a deep learning algorithm described Thursday in The Lancet Digital Health, converts a simple headshot into a number that more accurately reflects a person's biological age rather than the birthday on their chart.
Trained on tens of thousands of photographs, it pegged cancer patients on average as biologically five years older than healthy peers. The study's authors say it could help doctors decide who can safely tolerate punishing treatments, and who might fare better with a gentler approach.
'We hypothesise that FaceAge could be used as a biomarker in cancer care to quantify a patient's biological age and help a doctor make these tough decisions,' said co-senior author Raymond Mak, an oncologist at Mass Brigham Health, a Harvard-affiliated health system in Boston.
Consider two hypothetical patients: a spry 75-year-old whose biological age clocks in at 65, and a frail 60-year-old whose biology reads 70. Aggressive radiation might be appropriate for the former but risky for the latter.
The same logic could help guide decisions about heart surgery, hip replacements or end-of-life care.
Sharper lens on frailty
Growing evidence shows humans age at different rates, shaped by genes, stress, exercise, and habits like smoking or drinking. While pricey genetic tests can reveal how DNA wears over time, FaceAge promises insight using only a selfie.
The model was trained on 58,851 portraits of presumed-healthy adults over 60, drawn from public datasets.
It was then tested on 6,196 cancer patients treated in the United States and the Netherlands, using photos taken just before radiotherapy. Patients with malignancies looked on average 4.79 years older biologically than their chronological age.
Among cancer patients, a higher FaceAge score strongly predicted worse survival — even after accounting for actual age, sex, and tumour type — and the hazard rose steeply for anyone whose biological reading tipped past 85.
Intriguingly, FaceAge appears to weigh the signs of ageing differently than humans do. For example, being grey-haired or balding matters less than subtle changes in facial muscle tone.
FaceAge boosted doctors' accuracy, too. Eight physicians were asked to examine headshots of terminal cancer patients and guess who would die within six months. Their success rate barely beat chance; with FaceAge data in hand, predictions improved sharply.
The model even affirmed a favourite internet meme, estimating actor Paul Rudd's biological age as 43 in a photo taken when he was 50.
Bias and ethics guardrails
AI tools have faced scrutiny for underserving non-white people. Mak said preliminary checks revealed no significant racial bias in FaceAge's predictions, but the group is training a second-generation model on 20,000 patients.
They are also probing how factors like makeup, cosmetic surgery or room lighting variations could fool the system.
Ethics debates loom large. An AI that can read biological age from a selfie could prove a boon for clinicians, but also tempting for life insurers or employers seeking to gauge risk.
'It is for sure something that needs attention, to assure that these technologies are used only in the benefit for the patient,' said Hugo Aerts, the study's co-lead who directs MGB's AI in medicine programme.
Another dilemma: what happens when the mirror talks back? Learning that your body is biologically older than you thought may spur healthy changes — or sow anxiety.
The researchers are planning to open a public-facing FaceAge portal where people can upload their own pictures to enrol in a research study to further validate the algorithm. Commercial versions aimed at clinicians may follow, but only after more validation. — AFP
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
5 hours ago
- Malay Mail
Inside the intricate science, engineering, and policy hurdles shaping Nasa, SpaceX's bid to send humans to Mars
WASHINGTON, June 6 — A crewed mission to Mars would rank among the most complex and costly undertakings in human history—and US President Donald Trump has vowed to make it a national priority. That political momentum, coupled with SpaceX chief Elon Musk's zeal, has breathed new life into a cause long championed by Red Planet advocates—even as major obstacles remain, including Trump and Musk's latest feud. Why go? As Nasa writes in its Moon to Mars blueprint, 'exploration of the cosmos remains a great calling for humanity.' A mission to Mars would pursue scientific objectives like determining whether Mars ever hosted life and charting the evolution of its surface, as well as answering broader space physics questions—such as the history of the Sun through studying Martian soil. Geopolitics also looms large, as Trump has pledged to 'plant the American flag on the planet Mars and even far beyond,' invoking the 'unlimited promise of the American dream.' Critics, however, say cuts to Nasa's science budget and the cancellation of key projects—including the return of rock samples collected by the Perseverance rover—are undermining the research mission. 'The purpose of exploration is not just to go somewhere,' Nobel-winning astrophysicist John Mather told AFP. 'This is not a tourist thing. This is a fundamental knowledge thing.' Getting there Musk is betting SpaceX's future on Starship, the largest rocket ever built, despite fiery failures in its nine test flights. He's aiming for an uncrewed launch by late 2026, timed with the next favorable Earth-Mars alignment. But the timeline is widely seen as optimistic: Starship has yet to land its upper stage or demonstrate in-orbit refueling—both essential for deep space travel. Some experts believe the system is fundamentally sound, while others say it's too soon to judge. 'A lot of the pertinent and relevant technical information... is not known to us,' Kurt Polzin, chief engineer for Nasa's space nuclear propulsion project, told AFP. He backs Nuclear Thermal Propulsion (NTP), which uses fission to heat hydrogen and generate thrust. NTP delivers 'a lot of power in a very small package,' Polzin said, eliminating the need for orbital refueling or fuel production on Mars. Astronauts would spend seven to nine months in a cramped spacecraft, exposed to intense space radiation beyond Earth's magnetosphere. Ideas to improve radiation shielding range from passive methods, like using dense materials, to active concepts such as plasma fields that deflect radiation, while drugs are being developed to reduce cell damage. Without a system to simulate gravity—such as rotational spin—crews would also need grueling exercise routines to counteract muscle and bone loss. Mental health is another concern. Growing plants aboard—more for morale than sustenance—has proved beneficial on the ISS. Communication delays further complicate matters. On the station, real-time data has helped prevent an average of 1.7 potentially fatal incidents per year, said Erik Antonsen, chair of NASA's human systems risk board—but such communication will not be possible en route to Mars. Life on Mars Once on the surface, the uncertainties grow. Probes and rovers have found hints—organic molecules, seasonal methane—but no definitive signs of life. If it ever existed, it likely died out long ago. Still, Earth's own 'extremophiles' offer intriguing clues—from fungi that harness Chernobyl's radiation for energy, to microbes that survived 500,000 years in frozen stasis. 'If they can survive here in extreme environments, we have every reason to suspect they can be on Mars,' said NASA astrobiologist Jennifer Eigenbrode at the recent Humans to the Moon and Mars Summit. And while NASA has decided nuclear fission will power surface operations, other choices—from crop selection to habitat design—remain open. 'Mars has a 24-hour, 39-minute day—that small difference creates strain, increases stress, and reduces sleep quality,' said Phnam Bagley, a space architect who designs for comfort and crew well-being—critical factors in preventing conflict. The first trip would be around 500 days on the surface, but long-term colonization raises deeper questions. For instance, scientists don't yet know whether mammalian embryos can develop in low gravity—or what childbirth on Mars would entail. 'I think it's really important to take that seriously,' said NASA's Antonsen. 'Even if you don't plan on it happening, people are still going to have sex, and somebody might get pregnant. Then it becomes a medical issue.' — AFP
The Star
8 hours ago
- The Star
Broadcom shares drop as revenue forecast fails to impress
A smartphone with a displayed Broadcom logo is placed on a computer motherboard in this illustration taken March 6, 2023. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) - Broadcom shares fell nearly 4% in premarket trading on Friday, after the company's third-quarter revenue forecast failed to impress investors who have been extremely bullish on chip stocks amid an artificial intelligence boom. The Palo Alto, California-based company, which supplies semiconductors to Apple and Samsung, provides advanced networking gear that allows vast amounts of data to travel across AI data centers, making its chips crucial for the development of generative AI technology. Broadcom forecast third-quarter revenue of around $15.80 billion, compared with analysts' average estimate of $15.71 billion, according to data compiled by LSEG. "High expectations drove a bit of downside," Bernstein analyst Stacy Rasgon said in a note. Broadcom also helps design custom AI processors for large cloud providers, which compete against Nvidia's pricey off-the-shelf chips. Global chipmakers, including Nvidia, have been vulnerable to U.S. President Donald Trump's shifting trade policy and export curbs as Washington attempts to limit Beijing's access to advanced U.S. technology. "AVGO is ramping two additional customers, but they are still small. So the processor business will grow this year, but at a measured rate," said Morgan Stanley. Last week, rival Marvell Technology forecast second-quarter revenue above Wall Street estimate, betting on strong demand for its custom chips powering AI workload in data centers. Broadcom's valuation had crossed $1 trillion for the first time in December after it forecast massive expansion in demand for chips that power AI. Its shares have risen about 12% so far this year. It has a 12-month forward price-to-earnings ratio of 35.36, compared with Marvell's 20.63, according to data compiled by LSEG. (Reporting by Twesha Dikshit in Bengaluru; Editing by Shilpi Majumdar)
Malay Mail
13 hours ago
- Malay Mail
OpenAI fights back in NYT copyright lawsuit over ChatGPT data freeze
NEW YORK, June 6 — OpenAI is appealing an order in a copyright case brought by the New York Times that requires it to preserve ChatGPT output data indefinitely, arguing that the order conflicts with privacy commitments it has made with users. Last month, a court said OpenAI had to preserve and segregate all output log data after the Times asked for the data to be preserved. 'We will fight any demand that compromises our users' privacy; this is a core principle,' OpenAI CEO Sam Altman said in a post on X yesterday. 'We think this (the Times demand) was an inappropriate request that sets a bad precedent.' US District Judge Sidney Stein was asked to vacate the May data preservation order on June 3, a court filing showed. The New York Times did not immediately respond to a request for comment outside regular business hours. The newspaper sued OpenAI and Microsoft in 2023, accusing them of using millions of its articles without permission to train the large language model behind its popular chatbot. Stein said in an April court opinion that the Times had made a case that OpenAI and Microsoft were responsible for inducing users to infringe its copyrights. The opinion explained an earlier order that rejected parts of an OpenAI and Microsoft motion to dismiss, saying that the Times' 'numerous' and 'widely publicised' examples of ChatGPT producing material from its articles justified allowing the claims to continue. — Reuters
